HeXun Biosciences Co Ltd(TW:6986)
NT$37.50+0.20 (+0.54%)
TW:6986
HeXun Biosciences Co Ltd financials statements
NT$37.50
At close:+0.20 (+0.54%)
HeXun Biosciences Co Ltd (6986) Income Statement
HeXun Biosciences Co Ltd Income Statement
Last quarter (Q2 2026), HeXun Biosciences Co Ltd's total revenue was NT$93.86M, an increase of 10.09% from the same quarter last year. In Q2, HeXun Biosciences Co Ltd's net income was NT$38.37M. See HeXun Biosciences Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 25 | Dec 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 130.57M | NT$ 293.23M | NT$ 286.42M | NT$ 49.47M | NT$ 0.00 | |
| NT$ 113.73M | NT$ 245.15M | NT$ 260.67M | NT$ 44.61M | NT$ 0.00 | |
| NT$ 86.36M | NT$ 127.15M | NT$ 104.94M | NT$ 53.59M | NT$ 50.66M | |
| Depreciation and Amortization | NT$ 20.30M | NT$ 28.94M | NT$ 24.71M | NT$ 14.72M | NT$ 11.91M |
| NT$ 55.64M | NT$ 146.95M | NT$ 187.36M | NT$ 11.17M | NT$ -29.51M | |
| NT$ 27.37M | NT$ 118.00M | NT$ 155.73M | NT$ -3.55M | NT$ -50.66M | |
| NT$ 6.12M | NT$ 7.92M | NT$ 5.74M | NT$ 3.79M | NT$ 7.68M | |
| NT$ 33.49M | NT$ 125.93M | NT$ 161.47M | NT$ -5.19M | NT$ -42.99M | |
| NT$ 33.49M | NT$ 111.91M | NT$ 147.22M | NT$ -5.19M | NT$ -42.99M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.89 | NT$ 2.43 | NT$ 3.20 | NT$ -0.14 | NT$ -1.41 |
| Diluted EPS | NT$ 0.89 | NT$ 2.43 | NT$ 3.20 | NT$ -0.14 | NT$ -1.41 |
| Weighted Average Shares Outstanding | 37.50M | 46.00M | 46.00M | 37.50M | 30.51M |
| Weighted Average Shares Outstanding (Diluted) | 37.50M | 46.02M | 46.03M | 37.50M | 30.51M |
Currency in TWD
